Safe and effective medicines for children : studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act / Committee on Pediatric Studies Conducted under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equality Act (PREA), Institute of Medicine of the National Academies ; edited by Marilyn J. Field and Thomas F. Boat.

"The Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) were designed to encourage more pediatric studies of drugs used for children. The FDA asked the IOM to review aspects of pediatric studies and changes in product labeling that resulted from BPCA and P...

Full description

Bibliographic Details

Corporate Authors:	Institute of Medicine (U.S.). Committee on Pediatric Studies Conducted under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equality Act (PREA), Institute of Medicine (U.S.). Board on Health Sciences Policy
Other Authors:	Field, Marilyn J. (Marilyn Jane), Boat, Thomas F.
Format:	eBook
Language:	English
Published:	Washington, D.C. : National Academies Press, 2012.
Subjects:	Pediatric pharmacology > Research > United States. Pediatric pharmacology > Law and legislation > United States. Drugs > United States > Testing. Pediatrics. Drugs. MEDICAL > Pharmacology. Pediatrics Drugs Drugs > Testing United States
Online Access:	Click for online access